Trial Profile
Modeling and Treating the Pathophysiology of Demyelination in Multiple Sclerosis
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 19 Apr 2013 Additional lead trial centre identified as reported by ClinicalTrials.gov.
- 04 Nov 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Mar 2009 New trial record